series-a
Stage
1
Investors
About
Curreio is a biotechnology company focused on drug discovery using cryo-electron microscopy (Cryo-EM). The company specializes in high-resolution protein structure analysis to aid in the creation of new medications.
Explore Curreio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.